{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:35:24Z","timestamp":1792290924773,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM121322"],"award-info":[{"award-number":["P20GM121322"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s11060-019-03309-6","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T19:55:01Z","timestamp":1572033301000},"page":"391-397","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Intraoperative radiotherapy (IORT) for surgically resected brain metastases: outcome analysis of an international cooperative study"],"prefix":"10.1007","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3147-2743","authenticated-orcid":false,"given":"Christopher P.","family":"Cifarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Brehmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Austin","family":"Vargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Hack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus Henning","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Sarria-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"issue":"suppl. 2","key":"3309_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1227\/NEU.0b013e31827b99f3","volume":"72","author":"B Atalar","year":"2013","unstructured":"Atalar B, Choi CY, Harsh GR et al (2013) Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery. Neurosurgery. 72(suppl. 2):180\u20135; (discussion 185)","journal-title":"Neurosurgery"},{"issue":"suppl. 5","key":"3309_CR2","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1158\/1078-0432.CCR-07-4453","volume":"14","author":"B Belletti","year":"2008","unstructured":"Belletti B, Vaidya JS, D'Andrea S et al (2008) Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding. Clin Cancer Res. 14(suppl. 5):1325\u20131332","journal-title":"Clin Cancer Res"},{"issue":"suppl. 8","key":"3309_CR3","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","volume":"18","author":"PD Brown","year":"2017","unstructured":"Brown PD, Ballman KV, Cerhan JH, et al (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC.3): A multicentre, randomised, controlled, phase 3 trial. Lancet Oncol;18(suppl. 8):1049\u20131060","journal-title":"Lancet Oncol"},{"issue":"suppl. 11","key":"3309_CR4","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","volume":"10","author":"EL Chang","year":"2009","unstructured":"Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10(suppl. 11):1037\u20131044","journal-title":"Lancet Oncol"},{"issue":"suppl. 9","key":"3309_CR5","first-page":"633","volume":"29","author":"M Charlton","year":"2015","unstructured":"Charlton M, Schlichting J, Chioreso C, Ward M, Vikas P (2015) Challenges of rural cancer care in the united states. Oncology (Williston Park) 29(suppl. 9):633\u2013640","journal-title":"Oncology (Williston Park)"},{"issue":"suppl. 1","key":"3309_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/neuros\/nyy018","volume":"84","author":"FA Giordano","year":"2019","unstructured":"Giordano FA, Brehmer S, Murle B et al (2019) Intraoperative radiotherapy in newly diagnosed glioblastoma (INTRAGO): an open-label, dose-escalation phase I\/II trial. Neurosurgery 84(suppl. 1):41\u201349","journal-title":"Neurosurgery"},{"issue":"suppl. 5","key":"3309_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/09553009314450721","volume":"63","author":"DT Goodhead","year":"1993","unstructured":"Goodhead DT, Thacker J, Cox R (1993) Weiss lecture. effects of radiations of different qualities on cells: molecular mechanisms of damage and repair. Int J Radiat Biol ;63(suppl. 5):543\u2013556","journal-title":"Int J Radiat Biol"},{"issue":"suppl. 1","key":"3309_CR8","first-page":"3","volume":"3","author":"C Herskind","year":"2014","unstructured":"Herskind C, Wenz F (2014) Radiobiological aspects of intraoperative tumour-bed irradiation with low-energy X-rays (LEX-IORT). Trans Cancer Res;3(suppl. 1):3-17","journal-title":"Transl Cancer Res"},{"issue":"suppl. 4","key":"3309_CR9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1227\/NEU.0000000000000626","volume":"76","author":"J Hsieh","year":"2015","unstructured":"Hsieh J, Elson P, Otvos B et al (2015) Tumor progression in patients receiving adjuvant whole-brain radiotherapy vs localized radiotherapy after surgical resection of brain metastases. Neurosurgery 76(suppl. 4):411\u2013420","journal-title":"Neurosurgery"},{"issue":"Suppl","key":"3309_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3171\/2014.7.GKS141488","volume":"121","author":"C Iorio-Morin","year":"2014","unstructured":"Iorio-Morin C, Masson-Cote L, Ezahr Y, Blanchard J, Ebacher A, Mathieu D (2014) Early gamma knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control. J Neurosurg 121(Suppl):69\u201374","journal-title":"J Neurosurg"},{"issue":"suppl. 4","key":"3309_CR11","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.ijrobp.2012.01.067","volume":"84","author":"LA Jarvis","year":"2012","unstructured":"Jarvis LA, Simmons NE, Bellerive M et al (2012) Tumor bed dynamics after surgical resection of brain metastases: implications for postoperative radiosurgery. Int J Radiat Oncol Biol Phys 84(suppl. 4):943\u2013948","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl. 2","key":"3309_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","volume":"29","author":"M Kocher","year":"2011","unstructured":"Kocher M, Soffietti R, Abacioglu U et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952\u201326001 study. J Clin Oncol 29(suppl. 2):134\u2013141","journal-title":"J Clin Oncol"},{"issue":"suppl. 1","key":"3309_CR13","first-page":"7891","volume":"9","author":"K Kulcenty","year":"2011","unstructured":"Kulcenty K, Piotrowski I, Zaleska K, et al (2019) Wound fluids collected postoperatively from patients with breast cancer induce epithelial to mesenchymal transition but intraoperative radiotherapy impairs this effect by activating the radiation-induced bystander effect. Sci Rep; 9(suppl. 1):7891","journal-title":"Sci Rep"},{"issue":"suppl. 8","key":"3309_CR14","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","volume":"18","author":"A Mahajan","year":"2017","unstructured":"Mahajan A, Ahmed S, McAleer MF et al (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol. 18(suppl. 8):1040\u20131048","journal-title":"Lancet Oncol."},{"key":"3309_CR15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3389\/fonc.2018.00342","volume":"8","author":"EM Marchan","year":"2018","unstructured":"Marchan EM, Peterson J, Sio TT et al (2018) Postoperative cavity stereotactic radiosurgery for brain metastases. Front Oncol 8:342","journal-title":"Front Oncol"},{"issue":"suppl. 8","key":"3309_CR16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199002223220802","volume":"322","author":"RA Patchell","year":"1990","unstructured":"Patchell RA, Tibbs PA, Walsh JW et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322(suppl. 8):494\u2013500","journal-title":"N Engl J Med"},{"issue":"suppl. 2","key":"3309_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.wneu.2015.03.052","volume":"84","author":"DM Patel","year":"2015","unstructured":"Patel DM, Agarwal N, Tomei KL, Hansberry DR, Goldstein IM (2015) Optimal timing of whole-brain radiation therapy following craniotomy for cerebral malignancies. World Neurosurg 84(suppl. 2):412\u2013419","journal-title":"World Neurosurg"},{"issue":"suppl. 2","key":"3309_CR18","first-page":"14","volume":"36","author":"I Piotrowski","year":"2018","unstructured":"Piotrowski I, Kulcenty K, Murawa D, Suchorska W (2018) Surgical wound fluids from patients treated with intraoperative radiotherapy induce radiobiological response in breast cancer cells. Med Oncol; 36(suppl. 2):14","journal-title":"Med Oncol"},{"issue":"suppl. 1","key":"3309_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1200\/JCO.2011.41.0639","volume":"31","author":"R Soffietti","year":"2013","unstructured":"Soffietti R, Kocher M, Abacioglu UM et al (2013) A european organisation for research and treatment of cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 31(suppl. 1):65\u201372","journal-title":"J Clin Oncol"},{"issue":"suppl. 2","key":"3309_CR20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ijrobp.2017.09.047","volume":"100","author":"H Soliman","year":"2018","unstructured":"Soliman H, Ruschin M, Angelov L et al (2018) Consensus contouring guidelines for postoperative completely resected cavity stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 100(suppl. 2):436\u2013442","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl. 1","key":"3309_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijrobp.2007.06.068","volume":"70","author":"SG Soltys","year":"2008","unstructured":"Soltys SG, Adler JR, Lipani JD et al (2008) Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys. 70(suppl. 1):187\u2013193","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl. 3","key":"3309_CR22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.adro.2019.03.002","volume":"4","author":"M Susko","year":"2019","unstructured":"Susko M, Yu Y, Ma L et al (2019) Preoperative dural contact and recurrence risk after surgical cavity stereotactic radiosurgery for brain metastases: new evidence in support of consensus guidelines. Adv Radiat Oncol 4(suppl. 3):458\u2013465","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"3309_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11060-019-03233-9","volume":"144","author":"JI Traylor","year":"2019","unstructured":"Traylor JI, Habib A, Patel R, et al (2019) Fractionated stereotactic radiotherapy for local control of resected brain metastases. J Neurooncol; 144(2):343-350","journal-title":"J Neurooncol"},{"issue":"suppl. 2","key":"3309_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11060-018-2968-4","volume":"140","author":"JA Vargo","year":"2018","unstructured":"Vargo JA, Sparks KM, Singh R, Jacobson GM, Hack JD, Cifarelli CP (2018) Feasibility of dose escalation using intraoperative radiotherapy following resection of large brain metastases compared to post-operative stereotactic radiosurgery. J Neurooncol 140(suppl. 2):413\u2013420","journal-title":"J Neurooncol"},{"issue":"suppl. 4","key":"3309_CR25","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3171\/2014.11.JNS1449","volume":"122","author":"RJ Weil","year":"2015","unstructured":"Weil RJ, Mavinkurve GG, Chao ST et al (2015) Intraoperative radiotherapy to treat newly diagnosed solitary brain metastasis: initial experience and long-term outcomes. J Neurosurg 122(suppl. 4):825\u2013832","journal-title":"J Neurosurg"},{"issue":"suppl. 3","key":"3309_CR26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s11060-017-2679-2","volume":"136","author":"MB Yusuf","year":"2018","unstructured":"Yusuf MB, Amsbaugh MJ, Burton E et al (2018) Increasing time to postoperative stereotactic radiation therapy for patients with resected brain metastases: Investigating clinical outcomes and identifying predictors associated with time to initiation. J Neurooncol 136(suppl. 3):545\u2013553","journal-title":"J Neurooncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03309-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-019-03309-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03309-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T23:09:07Z","timestamp":1603494547000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-019-03309-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["3309"],"URL":"https:\/\/doi.org\/10.1007\/s11060-019-03309-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"assertion":[{"value":"19 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Kahl reports personal fees from ELEKTA AB, personal fees from Varian, outside of the submitted work. Dr. Sarria reports grants and personal fees from Carl Zeiss Meditec AG, outside of the submitted work. Dr. Giordano reports grants and personal fees from Carl Zeiss Meditec AG, during the conduct of the study; grants and personal fees from NOXXON Pharma AG, grants and personal fees from ELEKTA AB, personal fees from Bristol-Myers Squibb, personal fees from Roche Pharma AG, personal fees from MSD Sharp and Dohme GmbH, personal fees from AstraZeneca GmbH, other from Implacit GmbH, non-financial support from Oncare GmbH, outside the submitted work; In addition, Dr. Giordano has a patent Radiation Therapy with Immune Response Monitoring (US 62\/435405) pending to Carl Zeiss Meditec AG. All other authors have no disclosures relevant to the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}